📣 VC round data is live. Check it out!

China Pacific Insurance Valuation Multiples

Discover revenue and EBITDA valuation multiples for China Pacific Insurance and similar public comparables like Great-West Lifeco, MetLife, Life Insurance Corporation of India, People's Insurance Co and more.

China Pacific Insurance Overview

About China Pacific Insurance

Established in 1988, China Pacific Insurance is China's third-largest life insurer and third-largest general property and casualty insurer, with headquarters in Beijing. The company strives to create an integrated financial services platform that encompasses insurance, banking, and asset management. CPIC's major shareholders are state-owned companies related to the Shanghai government.


Founded

1991

HQ

China

Employees

95.0K

Financials (LTM)

Revenue: $65B
EBITDA: $8B

EV

$40B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

China Pacific Insurance Financials

China Pacific Insurance reported last 12-month revenue of $65B and EBITDA of $8B.

In the same LTM period, China Pacific Insurance generated $8B in EBITDA and $8B in net income.

Revenue (LTM)


China Pacific Insurance P&L

In the most recent fiscal year, China Pacific Insurance reported revenue of $64B and EBITDA of $8B.

China Pacific Insurance is profitable as of last fiscal year, with EBITDA margin of 12% and net margin of 12%.

See analyst estimates for China Pacific Insurance
LTMLast FY202320242025202620272028
Revenue$65B$64B$47B$59B$63B
EBITDA$8B$8B——$8B
EBITDA Margin12%12%——12%
EBIT Margin14%15%——15%
Net Profit$8B$8B$4B$7B$8B
Net Margin12%12%8%11%12%

Financial data powered by Morningstar, Inc.

China Pacific Insurance Stock Performance

China Pacific Insurance has current market cap of $49B, and enterprise value of $40B.

Market Cap Evolution


China Pacific Insurance's stock price is $5.13.

China Pacific Insurance share price increased by 0.1% in the last 30 days, and by 14.0% in the last year.

China Pacific Insurance has an EPS (earnings per share) of $0.81.

See more trading valuation data for China Pacific Insurance
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$40B$49B-0.2%0.1%-8.2%14.0%$0.81

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

China Pacific Insurance Valuation Multiples

China Pacific Insurance trades at 0.6x EV/Revenue multiple, and 4.9x EV/EBITDA.

See NTM and 2027E valuation multiples for China Pacific Insurance

EV / Revenue (LTM)


China Pacific Insurance Financial Valuation Multiples

As of May 8, 2026, China Pacific Insurance has market cap of $49B and EV of $40B.

China Pacific Insurance has a P/E ratio of 6.4x.

LTMLast FY202320242025202620272028
EV/Revenue0.6x0.6x0.8x0.7x0.6x
EV/EBITDA4.9x5.2x——5.2x
EV/EBIT4.2x4.3x——4.3x
P/E6.4x6.3x12.4x7.5x6.3x
EV/FCF—1.4x2.0x1.8x1.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified China Pacific Insurance Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

China Pacific Insurance Margins & Growth Rates

China Pacific Insurance grew revenue by 4% and EBITDA by 18% in the last fiscal year.

In the most recent fiscal year, China Pacific Insurance reported EBITDA margin of 12% and net margin of 12%.

See estimated margins and future growth rates for China Pacific Insurance

China Pacific Insurance Margins

Last FY202420252026202720282029
EBITDA Margin12%—12%13%
EBIT Margin15%—15%14%
Net Margin12%11%12%12%
FCF Margin44%37%44%—

China Pacific Insurance Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%25%7%6%
EBITDA Growth18%——18%
EBIT Growth3%——3%
Net Profit Growth(1%)65%19%(1%)
FCF Growth—12%27%—

Data powered by FactSet, Inc. and Morningstar, Inc.

China Pacific Insurance Operational KPIs

China Pacific Insurance's revenue per employee in the last FY averaged $0.7M.

China Pacific Insurance's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

China Pacific Insurance's Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for China Pacific Insurance
LTMLast FY202320242025202620272028
Rule of 4017%19%———
Bessemer Rule of X24%28%———
Revenue per Employee—$0.7M———
G&A Expenses to Revenue2%2%2%2%2%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

China Pacific Insurance Competitors

China Pacific Insurance competitors include Great-West Lifeco, MetLife, Life Insurance Corporation of India, People's Insurance Co, Allstate, AIG, Sun Life, Aflac, Fubon Financial and PICC Property & Casualty.

Most China Pacific Insurance public comparables operate across Insurance Carriers.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Great-West Lifeco1.9x15.3x——
MetLife0.9x0.9x7.4x7.3x
Life Insurance Corporation of India0.5x0.5x—11.6x
People's Insurance Co0.5x0.5x——
Allstate1.0x1.1x5.1x5.5x
AIG1.8x1.8x11.8x10.3x
Sun Life1.8x7.5x12.4x12.2x
Aflac3.5x3.6x11.7x12.0x

This data is available for Pro users. Sign up to see all China Pacific Insurance competitors and their valuation data.

Start Free Trial

China Pacific Insurance Investment Activity

China Pacific Insurance has invested in 11 companies to date.

Latest investment by China Pacific Insurance was on May 8th 2024. China Pacific Insurance invested in Taiyi Guanjia in their $127M Seed round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by China Pacific Insurance

Taiyi Guanjia
Bang Er Orthopedic
Tripod Preclinical Research Laboratories
Safe Medical Evaluation
Description
—
Bang Er Orthopedic is a specialized hospital operator in China's Yangtze River Delta region. Zhejiang Boner Medical Investment Management Co., Ltd. oversees its network of facilities focused on orthopedics and rehabilitation services. The chain provides advanced treatments for bone injuries, joint disorders, and post-surgical recovery, serving patients in Shanghai, Hangzhou, and surrounding areas.
Tripod Preclinical Research Laboratories is a contract research organization offering GLP-compliant nonclinical safety evaluation services. Taoyuan, Taiwan-based, it conducts toxicology studies, pharmacokinetics, and pathology assessments for new chemical entities, biologics, pesticides, veterinary drugs, and cosmetics targeting global pharmaceutical and biotech clients.
Safe Medical Evaluation is a Beijing-based institute for drug safety testing. Beijing Saifu Medical Research Institute Co., Ltd. partners with the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and Beijing's National Drug Safety Evaluation and Research Center. Its team, drawn from the Academy of Military Medical Sciences, specializes in GLP-compliant toxicology and drug development platforms.
HQ CountryChinaChinaChinaChina
HQ City
—
Hangzhou
Nanjing
Beijing
Deal Date8 May 20249 Nov 202312 Apr 20232 Dec 2022
RoundSeedSeries ESeries CSeries D
Raised$127M$111M$6M$72M
InvestorsChina Pacific Insurance; HSG; Mitsui Sumitomo Insurance Company; Shanghai International Asset ManagementC&D Emerging Investment; China Pacific Insurance; Gaoyuan Capital; Lake Bleu Capital; October Capital; Sunshine Insurance GroupChina Pacific Insurance; GL Ventures LLC; Highlight Capital; Hillhouse Ventures; HJ-Investment; Howbuy; Legend Capital; Shanghai Lingang Economic Development; Xiaochi CapitalChina Pacific Insurance; China State-Owned Capital Venture Investment Fund; CICC; FOF Capital; Jianxing Medical Fund; Lite Medical Fund; SDIC Venture Capital; Taiping Medical and Health Fund
Valuationundisclosed$700Mundisclosed$574M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all China Pacific Insurance investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About China Pacific Insurance

When was China Pacific Insurance founded?China Pacific Insurance was founded in 1991.
Where is China Pacific Insurance headquartered?China Pacific Insurance is headquartered in China.
How many employees does China Pacific Insurance have?As of today, China Pacific Insurance has over 95K employees.
Is China Pacific Insurance publicly listed?Yes, China Pacific Insurance is a public company listed on Shanghai Stock Exchange.
What is the stock symbol of China Pacific Insurance?China Pacific Insurance trades under 601601 ticker.
When did China Pacific Insurance go public?China Pacific Insurance went public in 2007.
Who are competitors of China Pacific Insurance?China Pacific Insurance main competitors include Great-West Lifeco, MetLife, Life Insurance Corporation of India, People's Insurance Co, Allstate, AIG, Sun Life, Aflac, Fubon Financial, PICC Property & Casualty.
What is the current market cap of China Pacific Insurance?China Pacific Insurance's current market cap is $49B.
What is the current revenue of China Pacific Insurance?China Pacific Insurance's last 12 months revenue is $65B.
What is the current revenue growth of China Pacific Insurance?China Pacific Insurance revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of China Pacific Insurance?Current revenue multiple of China Pacific Insurance is 0.6x.
Is China Pacific Insurance profitable?Yes, China Pacific Insurance is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of China Pacific Insurance?China Pacific Insurance's last 12 months EBITDA is $8B.
What is China Pacific Insurance's EBITDA margin?China Pacific Insurance's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of China Pacific Insurance?Current EBITDA multiple of China Pacific Insurance is 4.9x.
How many companies China Pacific Insurance has acquired to date?China Pacific Insurance hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies China Pacific Insurance has invested to date?As of May 2026, China Pacific Insurance has invested in 11 companies.
What was the last China Pacific Insurance investment?On 8th May 2024 China Pacific Insurance invested in Taiyi Guanjia, participating in a $127M Seed round, alongside HSG, Mitsui Sumitomo Insurance Company, and Shanghai International Asset Management.
In what companies China Pacific Insurance invested in?China Pacific Insurance invested in Shanghai Cell Therapy Group, Taiyi Guanjia, Bang Er Orthopedic, Metromile, Miao, Safe Medical Evaluation, Atzuche, Bochewang, E Yang Che, Tripod Preclinical Research Laboratories, and C-Health.

See public comps similar to China Pacific Insurance

Lists including China Pacific Insurance

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial